Literature DB >> 27351871

The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.

Reona Morio1, Hideyuki Hyogo2,3, Masahiro Hatooka1, Kei Morio1, Hiromi Kan1, Tomoki Kobayashi1, Tomokazu Kawaoka1, Masataka Tsuge1, Akira Hiramatsu1, Michio Imamura1, Yoshiiku Kawakami1, Hiroshi Aikata1, Hidenori Ochi1, Yoneda Masayasu4, Kazuaki Chayama1.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is frequently associated with insulin resistance (IR) and abnormalities in glucose metabolism. Prevalent postprandial hyperinsulinemia along with insulin resistance in NAFLD may lead to hypoglycemia. This study investigated the prevalence of postprandial oxyhypoglycemia in patients with NAFLD.
METHODS: The oral glucose tolerance test (OGTT) with 75 g glucose was performed in 375 biopsy-proven NAFLD patients with prior unknown type 2 diabetes mellitus (DM). Serum glucose and insulin levels were measured for 3 h after glucose loading and the clinical parameters were compared.
RESULTS: Normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and DM were observed in 36, 36, and 28 %, respectively. Hypoglycemia (≤70 mg/dL) after 3 h was observed in 14.4 % of all patients. The rate of hypoglycemia was significantly higher in NGT (63 % of NGT) than in IGT (30 % of IGT) and DM (7 % of DM) (P < 0.05). In patients with hypoglycemia, the levels of insulin were significantly higher at 30 and 60 min than those without hypoglycemia (P < 0.05). By multivariate analysis, high-LDL cholesterolemia (P < 0.05), low-HDL cholesterolemia (P < 0.05), and fibrosis (P < 0.05) were significant factors that contributed to hypoglycemia after 3 h on 75 g OGTT.
CONCLUSIONS: A relatively higher proportion of NAFLD cases exhibited transient postprandial hypoglycemia after 3 h on OGTT, especially in NAFLD patients with early-stage fibrosis. By performing 75 g OGTT for 3 h, hypoglycemia would be diagnosed earlier and the treatment intervention would decrease the progression of NAFLD and deterioration of glucose metabolism.

Entities:  

Keywords:  75 g OGTT; Hyperinsulinemia; Hypoglycemia; Nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2016        PMID: 27351871     DOI: 10.1007/s00535-016-1236-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  41 in total

1.  Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus.

Authors:  Yuki Kimura; Hideyuki Hyogo; Tomokazu Ishitobi; Yoshitaka Nabeshima; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 4.029

2.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 3.  A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

Authors:  Claire Z Larter; Shiv Chitturi; Déborah Heydet; Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2010-04       Impact factor: 4.029

4.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

5.  Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.

Authors:  Fernando Bril; Romina Lomonaco; Beverly Orsak; Carolina Ortiz-Lopez; Amy Webb; Fermin Tio; Joan Hecht; Kenneth Cusi
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425

Review 6.  Non-alcoholic fatty liver disease pathogenesis: the present and the future.

Authors:  S Petta; C Muratore; A Craxì
Journal:  Dig Liver Dis       Date:  2009-02-14       Impact factor: 4.088

7.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

8.  Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.

Authors:  Takashi Nakahara; Hideyuki Hyogo; Masato Yoneda; Yoshio Sumida; Yuichiro Eguchi; Hideki Fujii; Masafumi Ono; Takumi Kawaguchi; Kento Imajo; Hiroshi Aikata; Saiyu Tanaka; Kazuyuki Kanemasa; Kazuma Fujimoto; Keizo Anzai; Toshiji Saibara; Michio Sata; Atushi Nakajima; Yoshito Itoh; Kazuaki Chayama; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2013-11-26       Impact factor: 7.527

9.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

10.  Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.

Authors:  Motoi Hashiba; Masafumi Ono; Hideyuki Hyogo; Yukio Ikeda; Kosei Masuda; Reiko Yoshioka; Yoichi Ishikawa; Yuri Nagata; Kensuke Munekage; Tsunehiro Ochi; Akira Hirose; Yasuko Nozaki-Fujimura; Shuhei Noguchi; Nobuto Okamoto; Kazuaki Chayama; Narufumi Suganuma; Toshiji Saibara
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more
  1 in total

1.  Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.

Authors:  Yusuke Oki; Masafumi Ono; Hideyuki Hyogo; Tsunehiro Ochi; Kensuke Munekage; Yasuko Nozaki; Akira Hirose; Kosei Masuda; Hiroshi Mizuta; Nobuto Okamoto; Toshiji Saibara
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-07       Impact factor: 2.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.